SHE:300705 - Hunan Jiudian Pharmaceutical Co Ltd

Hunan Jiudian Pharmaceutical C
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2014 Q2	2014 Q4	2015 Q2	2015 Q4	2016 Q1	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	453.63M 63.1%	397.86M -12.3%	498.06M 25.2%	449.06M -9.8%	581.9M 29.6%	568.21M -2.4%	727.04M 28.0%	501.87M -31.0%	715.84M 42.6%	675.22M -5.7%	799.58M 18.4%	590.9M -26.1%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	92.61M 47.5%	81.15M -12.4%	113.36M 39.7%	93.86M -17.2%	132.47M 41.1%	120.85M -8.8%	169.79M 40.5%	125.94M -25.8%	145.14M 15.2%	145.53M 0.3%	198.61M 36.5%	161.67M -18.6%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	361.02M 67.7%	316.71M -12.3%	384.71M 21.5%	355.2M -7.7%	449.43M 26.5%	447.36M -0.5%	557.25M 24.6%	375.93M -32.5%	570.7M 51.8%	529.69M -7.2%	600.97M 13.5%	429.23M -28.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	373.12M 68.0%	331.1M -11.3%	444.13M 34.1%	381.2M -14.2%	489.12M 28.3%	478.51M -2.2%	655.63M 37.0%	415.92M -36.6%	586.32M 41.0%	529.78M -9.6%	747.89M 41.2%	443.59M -40.7%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	280.52M 76.1%	249.95M -10.9%	330.77M 32.3%	287.34M -13.1%	356.65M 24.1%	357.66M 0.3%	485.84M 35.8%	289.98M -40.3%	441.18M 52.1%	384.25M -12.9%	549.28M 42.9%	281.93M -48.7%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	80.51M 43.6%	66.77M -17.1%	53.93M -19.2%	67.86M 25.8%	92.78M 36.7%	89.7M -3.3%	71.41M -20.4%	85.96M 20.4%	129.52M 50.7%	145.44M 12.3%	51.69M -64.5%	147.3M 185.0%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	112.82M -	-	-	-	129.77M -	-	-	-	197.63M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	66.37M 42.9%	56.4M -15.0%	35.03M -37.9%	55.97M 59.7%	73.8M 31.9%	78.62M 6.5%	61.31M -22.0%	76.89M 25.4%	120.74M 57.0%	112.36M -6.9%	58.27M -48.1%	125.67M 115.7%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.197 38.0%	0.18 -8.7%	0.1 -44.4%	0.17 70%	0.22 29.4%	0.24 9.1%	0.19 -20.8%	0.157 -17.3%	0.257 63.6%	0.229 -11.1%	0.121 -46.9%	0.257 111.8%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.197 38.0%	0.18 -8.7%	0.1 -44.4%	0.17 70%	0.22 29.4%	0.24 9.1%	0.19 -20.8%	0.157 -17.3%	0.257 63.6%	0.229 -11.1%	0.121 -46.9%	0.257 111.8%